- Study from NCPA sheds new light on med synchronization programs
- Senate passes Drug Quality and Security Act
- Report: Specialty pharmacy to account for half of all prescription revenue by 2018
- NCPA: Community pharmacy has historically helped patients as they transition to new health plans
- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
CARY, N.C. — Entera Health has launched a new prescription medical food product for patients with intestinal disorders, the company said.
The drug maker announced the availability of EnteraGam (serum-derived bovine immunoglobulin protein isolate, SBI) for patients with chronic loose or frequent stools due to irritable bowel syndrome or HIV. The drug is meant to treat patients who have limited or impaired ability to ingest, digest, absorb or metabolize ordinary foodstuffs or certain nutrients.
The company is offering a savings program allowing insured patients to pay as little as $25 for their prescriptions. The program will be available in more than 40,000 pharmacies, the company said.